Characterization of biotin interference in 21 Vitros 5600 immunoassays and risk mitigation for patient safety at a large academic medical center.

[1]  H. Luu,et al.  Further assessment of the prevalence of biotin supplementation and its impact on risk. , 2019, Clinical Biochemistry.

[2]  A. Jaffe,et al.  Prevalence of biotin supplement usage in outpatients and plasma biotin concentrations in patients presenting to the emergency department. , 2018, Clinical biochemistry.

[3]  D. Maiter,et al.  Interferences With Thyroid Function Immunoassays: Clinical Implications and Detection Algorithm , 2018, Endocrine reviews.

[4]  H. Stieglitz,et al.  Suspected Testosterone-Producing Tumor in a Patient Taking Biotin Supplements , 2018, Journal of the Endocrine Society.

[5]  A. Dasgupta,et al.  Biotin at High Concentration Interferes with the LOCI Digoxin Assay but the PETINIA Phenytoin Assay Is Not Affected. , 2018, Annals of Clinical and Laboratory Science.

[6]  K. Sikaris,et al.  Characterization of the scope and magnitude of biotin interference in susceptible Roche Elecsys competitive and sandwich immunoassays , 2018, Annals of clinical biochemistry.

[7]  J. Hodges,et al.  Association of Biotin Ingestion With Performance of Hormone and Nonhormone Assays in Healthy Adults , 2017, JAMA.

[8]  N. Frey,et al.  Population pharmacokinetics of exogenous biotin and the relationship between biotin serum levels and in vitro immunoassay interference , 2017 .

[9]  S. Devaraj,et al.  Discordant Analytical Results Caused by Biotin Interference on Diagnostic Immunoassays in a Pediatric Hospital. , 2017, Annals of clinical and laboratory science.

[10]  J. Hidal,et al.  Biotin interference in immunoassays mimicking subclinical Graves’ disease and hyperestrogenism: a case series , 2017, Clinical chemistry and laboratory medicine.

[11]  P. Chanson,et al.  A Somewhat Bizarre Case of Graves Disease Due to Vitamin Treatment , 2017, Journal of the Endocrine Society.

[12]  P. Fauré,et al.  Biotin in multiple sclerosis and false biological hyperthyroidism: Mind the interference. , 2017, Revue neurologique (Paris).

[13]  W. Woodmansee,et al.  HIGH-DOSE BIOTIN TREATMENT FOR SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS MAY INTERFERE WITH THYROID ASSAYS. , 2016, AACE clinical case reports.

[14]  M. Clanet,et al.  MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study , 2016, Multiple sclerosis.

[15]  F. Distelmaier,et al.  Biotin Treatment Mimicking Graves' Disease. , 2016, The New England journal of medicine.

[16]  K. Sikaris,et al.  A caution regarding high‐dose biotin therapy: misdiagnosis of hyperthyroidism in euthyroid patients , 2016, Medical Journal of Australia.

[17]  M. Elston,et al.  Factitious Graves' Disease Due to Biotin Immunoassay Interference-A Case and Review of the Literature. , 2016, The Journal of clinical endocrinology and metabolism.

[18]  G. Barbesino.  Misdiagnosis of Graves' Disease with Apparent Severe Hyperthyroidism in a Patient Taking Biotin Megadoses. , 2016, Thyroid : official journal of the American Thyroid Association.

[19]  D. Mock,et al.  Pharmacokinetics and pharmacodynamics of MD1003 (high-dose biotin) in the treatment of progressive multiple sclerosis , 2016, Expert opinion on drug metabolism & toxicology.

[20]  M. Alfadhel,et al.  Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new cases , 2013, Orphanet Journal of Rare Diseases.

[21]  M. Milas,et al.  Falsely low parathyroid hormone secondary to biotin interference: a case series. , 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[22]  M. Baumgartner.  Vitamin-responsive disorders: cobalamin, folate, biotin, vitamins B1 and E. , 2013, Handbook of clinical neurology.

[23]  Irwin Klein,et al.  Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. , 2012, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[24]  J. Doery,et al.  Positive and negative interference in immunoassays following biotin ingestion: a pharmacokinetic study. , 2012, Pathology.

[25]  M. Chan,et al.  Biotin interference on TSH and free thyroid hormone measurement. , 2012, Pathology.

[26]  L. Sokoll,et al.  A case of renal osteodystrophy with unexpected serum intact parathyroid hormone concentrations. , 2009, Clinical chemistry.

[27]  J. Zempleni,et al.  Biotin and biotinidase deficiency , 2008, Expert review of endocrinology & metabolism.

[28]  U. P. S. T. Force.  Screening for Thyroid Disease: Recommendation Statement , 2004, Annals of Internal Medicine.

[29]  S. Sobki,et al.  Interference by Biotin Therapy on Measurement of TSH and FT4 by Enzymeimmunoassay on Boehringer Mannheim ES700 Analyser , 1996, Annals of clinical biochemistry.